Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2025 Earnings Call Transcript August 11, 2025
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.025.
Operator: Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Taylor Krafchik, Senior Vice President at Ellipsis TA. Please go ahead.
Taylor...
